These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 12719203

  • 1. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin.
    van Walraven C, Hart RG, Wells GA, Petersen P, Koudstaal PJ, Gullov AL, Hellemons BS, Koefed BG, Laupacis A.
    Arch Intern Med; 2003 Apr 28; 163(8):936-43. PubMed ID: 12719203
    [Abstract] [Full Text] [Related]

  • 2. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S, Trappolini M, Chillotti FM.
    Minerva Cardioangiol; 2001 Feb 28; 49(1):1-13. PubMed ID: 11279381
    [Abstract] [Full Text] [Related]

  • 3. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun 28; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 4. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
    Thomson R, Eccles M, Wood R, Chinn DJ.
    Med Decis Making; 2007 Jun 28; 27(4):438-47. PubMed ID: 17641140
    [Abstract] [Full Text] [Related]

  • 5. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH.
    Clin Ther; 2008 Sep 28; 30(9):1726-36. PubMed ID: 18840379
    [Abstract] [Full Text] [Related]

  • 6. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 28; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 7. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, ACTIVE W Investigators.
    J Am Coll Cardiol; 2007 Nov 27; 50(22):2156-61. PubMed ID: 18036454
    [Abstract] [Full Text] [Related]

  • 8. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
    Lip GY, Connolly S, Yusuf S, Shestakovska O, Flaker G, Hart R, Lanas F, Xavier D, Eikelboom J, ERROES Investigators.
    Circ Arrhythm Electrophysiol; 2013 Feb 27; 6(1):31-8. PubMed ID: 23390125
    [Abstract] [Full Text] [Related]

  • 9. Improving stroke risk stratification in atrial fibrillation.
    Lip GY, Halperin JL.
    Am J Med; 2010 Jun 27; 123(6):484-8. PubMed ID: 20569748
    [Abstract] [Full Text] [Related]

  • 10. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG, Albers GW.
    J Am Coll Cardiol; 2004 Mar 17; 43(6):929-35. PubMed ID: 15028346
    [Abstract] [Full Text] [Related]

  • 11. Clinical prediction rules to stratify short-term risk of stroke among patients diagnosed in the emergency department with a transient ischemic attack.
    Shah KH, Metz HA, Edlow JA.
    Ann Emerg Med; 2009 May 17; 53(5):662-73. PubMed ID: 18849093
    [Abstract] [Full Text] [Related]

  • 12. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH, Halperin JL.
    Geriatrics; 2007 Mar 17; 62(3):22-7. PubMed ID: 17346095
    [Abstract] [Full Text] [Related]

  • 13. [Incidence and risk factors of stroke in patients with nonvalvular atrial fibrillation in Haikou].
    Zeng M, Wu ZY, Zheng Y, Chen J, Feng GQ, Fu XH.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep 17; 40(5):905-8. PubMed ID: 19950611
    [Abstract] [Full Text] [Related]

  • 14. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
    Eikelboom JW, Connolly SJ, Gao P, Paolasso E, De Caterina R, Husted S, O'Donnell M, Yusuf S, Hart RG.
    J Stroke Cerebrovasc Dis; 2012 Aug 17; 21(6):429-35. PubMed ID: 22818021
    [Abstract] [Full Text] [Related]

  • 15. Differences among clinical classification schemes for predicting stroke in atrial fibrillation: implications for therapy in daily practice.
    Laguna P, Martín A, Del Arco C, Millán I, Gargantilla P, Spanish Atrial Fibrillation in Emergency Medicine Study Group (GEFAUR-2).
    Acad Emerg Med; 2005 Sep 17; 12(9):828-34. PubMed ID: 16141016
    [Abstract] [Full Text] [Related]

  • 16. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
    Tangelder MJ, Frison L, Weaver D, Wilcox RG, Bylock A, Emanuelsson H, Held P, Oldgren J.
    Am Heart J; 2008 Feb 17; 155(2):382-7. PubMed ID: 18215612
    [Abstract] [Full Text] [Related]

  • 17. A risk score to predict silent myocardial ischemia in patients with coronary artery disease under aspirin therapy presenting with upper gastrointestinal hemorrhage.
    Chen CC, Chong CF, Kuo CD, Wang TL.
    Am J Emerg Med; 2007 May 17; 25(4):406-13. PubMed ID: 17499658
    [Abstract] [Full Text] [Related]

  • 18. [Antithrombotic therapy in atrial fibrillation].
    Farré J, Navarro F, Romero J, Rivas D, Manuel Rubio J, Sanziani L.
    Rev Esp Cardiol; 1996 May 17; 49 Suppl 2():42-9. PubMed ID: 8755695
    [Abstract] [Full Text] [Related]

  • 19. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
    Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL, National Heart, Lung, and Blood Institute AFFIRM Investigators.
    Arch Intern Med; 2005 May 23; 165(10):1185-91. PubMed ID: 15911734
    [Abstract] [Full Text] [Related]

  • 20. Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.
    Lip GY, Frison L, Grind M, SPORTIF Investigators.
    J Intern Med; 2008 Jul 23; 264(1):50-61. PubMed ID: 18266660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.